Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
162.6 USD | +3.90% | +9.48% | -9.82% |
Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
Apr. 23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.82% | 16.36B | |
-1.42% | 104B | |
+6.77% | 97.47B | |
+5.71% | 22.25B | |
-12.92% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
+7.95% | 14.39B | |
+36.11% | 12.37B | |
+304.14% | 8.43B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- Bernstein Adjusts BeiGene's Price Target to $161 From $196, Maintains Market Perform Rating